Azenta, Inc. (NASDAQ:AZTA – Get Free Report) SVP Olga Pirogova sold 548 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total transaction of $21,958.36. Following the completion of the sale, the senior vice president now directly owns 19,373 shares of the company’s stock, valued at $776,276.11. The trade was a 2.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Azenta Stock Down 0.8 %
Shares of AZTA opened at $45.16 on Friday. The stock’s 50 day moving average is $45.22 and its two-hundred day moving average is $50.12. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16.
Azenta (NASDAQ:AZTA – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. Azenta’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.13 earnings per share. As a group, analysts anticipate that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.
Institutional Trading of Azenta
Wall Street Analysts Forecast Growth
Several analysts have commented on AZTA shares. Evercore ISI reduced their price objective on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC cut their price target on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Azenta presently has an average rating of “Hold” and an average target price of $63.60.
View Our Latest Stock Analysis on Azenta
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
- Five stocks we like better than Azenta
- High Flyers: 3 Natural Gas Stocks for March 2022
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Investing in Construction Stocks
- MarketBeat Week in Review – 11/18 – 11/22
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.